Trial Profile
Tolerance and Acceptability of Glibentek in Patients With Neonatale Diabetes Secondary to Mutations in K+-ATP Channels
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Glibenclamide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms NEOGLI
- 28 Feb 2018 New trial record